Cargando…

Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In Vitro

With over 50 million currently confirmed cases worldwide, including more than 1.3 million deaths, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a major impact on the economy and health care system. Currently, limited prophylactic or therapeutic intervention options ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holwerda, Melle, V’kovski, Philip, Wider, Manon, Thiel, Volker, Dijkman, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760777/ https://www.ncbi.nlm.nih.gov/pubmed/33256227 http://dx.doi.org/10.3390/microorganisms8121872

Ejemplares similares

Comprehensive single cell analysis of pandemic influenza A virus infection in the human airways uncovers cell-type specific host transcriptional signatures relevant for disease progression and pathogenesis
por: Kelly, Jenna N., et al.
Publicado: (2022)

Time-resolved characterization of the innate immune response in the respiratory epithelium of human, porcine, and bovine during influenza virus infection
por: Laloli, Laura, et al.
Publicado: (2022)

Disparate temperature-dependent virus–host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium
por: V’kovski, Philip, et al.
Publicado: (2021)

SARS-CoV-2 Inhibition by Sulfonated Compounds
por: Gasbarri, Matteo, et al.
Publicado: (2020)

Coronavirus biology and replication: implications for SARS-CoV-2
por: V’kovski, Philip, et al.
Publicado: (2020)

Establishment of a Reverse Genetic System from a Bovine Derived Influenza D Virus Isolate
por: Holwerda, Melle, et al.
Publicado: (2021)

No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection
por: García-Nicolás, Obdulio, et al.
Publicado: (2021)

Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols
por: Kratzel, Annika, et al.
Publicado: (2020)

Temperature-dependent surface stability of SARS-CoV-2
por: Kratzel, Annika, et al.
Publicado: (2020)

New insights on the role of paired membrane structures in coronavirus replication
por: V’kovski, Philip, et al.
Publicado: (2015)

Antiviral activity of K22 against members of the order Nidovirales
por: Rappe, Julie Christiane Françoise, et al.
Publicado: (2018)

Susceptibility of Well-Differentiated Airway Epithelial Cell Cultures from Domestic and Wild Animals to Severe Acute Respiratory Syndrome Coronavirus 2
por: Gultom, Mitra, et al.
Publicado: (2021)

The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor
por: García-Nicolás, Obdulio, et al.
Publicado: (2018)

Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling
por: V'kovski, Philip, et al.
Publicado: (2019)

A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets
por: Kratzel, Annika, et al.
Publicado: (2021)

Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle
por: Cong, Yingying, et al.
Publicado: (2020)

Determining the Replication Kinetics and Cellular Tropism of Influenza D Virus on Primary Well-Differentiated Human Airway Epithelial Cells
por: Holwerda, Melle, et al.
Publicado: (2019)

Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
por: Zettl, Ferdinand, et al.
Publicado: (2020)

Prevalence of BRD-Related Viral Pathogens in the Upper Respiratory Tract of Swiss Veal Calves
por: Studer, Eveline, et al.
Publicado: (2021)

Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response
por: Hirzel, Cédric, et al.
Publicado: (2022)

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2022)

Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation
por: Tabata, Keisuke, et al.
Publicado: (2021)

Photodynamic Inactivation of SARS-CoV-2 Infectivity and Antiviral Treatment Effects In Vitro
por: Ziganshyna, Svitlana, et al.
Publicado: (2022)

Author's overview: identifying SARS-CoV-2 antiviral compounds
por: Diffley, John F.X.
Publicado: (2021)

Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery
por: Chiu, Winston, et al.
Publicado: (2023)

Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico study
por: Indari, Omkar, et al.
Publicado: (2022)

Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses
por: Hamming, Ole J, et al.
Publicado: (2013)

In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2021)

In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
por: Chen, F, et al.
Publicado: (2004)

SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021)

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
por: Essa, Raahilah Zahir, et al.
Publicado: (2022)

Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro
por: Wang, Xi, et al.
Publicado: (2023)

APOBEC3-mediated restriction of RNA virus replication
por: Milewska, Aleksandra, et al.
Publicado: (2018)

An in vitro antiviral activity of iodine complexes against SARS-CoV-2
por: Altaf, Imran, et al.
Publicado: (2021)

In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2
por: Villalobos-Sánchez, Erendira, et al.
Publicado: (2023)

In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition
por: Ničkčović, Vanja P., et al.
Publicado: (2022)

Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404
por: Fàbrega-Ferrer, Montserrat, et al.
Publicado: (2022)

SARS-CoV and IFN: Too Little, Too Late
por: Kindler, Eveline, et al.
Publicado: (2016)

In Vitro Bioavailability Study of an Antiviral Compound Enisamium Iodide
por: Haltner-Ukomadu, Eleonore, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1p115kvb5e2unbaicm19obmpmb